Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab disease activity and serum level monitoring between infusions in rheumatoid arthritis
NL-OMON31619Phase 4Not yet recruiting
- Sponsor
- Sint Maartenskliniek
- Start
- Mar 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4 trial of infliximab, sponsored by Sint Maartenskliniek. Planned start Mar 2008; status: not yet recruiting.
02
Drugs
infliximab
Beyond the preview
Go deeper on NL-OMON31619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31619.